Page last updated: 2024-08-21

pyrazines and Nephritis

pyrazines has been researched along with Nephritis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abd El Motteleb, DM; Elshazly, SM1
Amann, K; Kalden, JR; Manz, RA; Maseda, D; Meister, S; Moser, K; Neubert, K; Voll, RE; Weisel, F; Wiethe, C; Winkler, TH1
Eller, K; Heininger, D; Huber, JM; Mayer, G; Rosenkranz, AR; Tagwerker, A1
Fuchi, N; Fujii, S; Iura, Y; Kaneko, H; Nishimura, K; Nitta, A; Sekiya, Y; Suyama, K; Takahashi, T; Ueda, H; Yamada, M; Yamaguchi, S1
Liang, J; Yang, HY; Yang, QZ1
Higuchi, C; Nakano, Y; Nihei, H; Nishimura, H; Omata, M; Sanaka, T; Shinobe, M; Sugino, N1

Other Studies

6 other study(ies) available for pyrazines and Nephritis

ArticleYear
Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor.
    European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3

    Topics: Animals; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glutathione Peroxidase; Hypertension; Hypertension, Renal; Hypoglycemic Agents; Kidney; Lipid Peroxidation; Male; Nephritis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrazines; Rats; Rats, Wistar; Receptors, Glucagon; Sitagliptin Phosphate; Superoxide Dismutase; Triazoles

2013
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
    Nature medicine, 2008, Volume: 14, Issue:7

    Topics: Animals; Boronic Acids; Bortezomib; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Mice, Inbred NZB; Models, Immunological; Nephritis; Ovalbumin; Plasma Cells; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Time Factors

2008
The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Boronic Acids; Bortezomib; CD4 Lymphocyte Count; Creatinine; Cyclin-Dependent Kinase Inhibitor p21; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Necrosis; Nephritis; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Reperfusion Injury; Time Factors

2009
Discovery and structure-activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2.
    Bioorganic & medicinal chemistry letters, 2012, Jul-01, Volume: 22, Issue:13

    Topics: Animals; Binding Sites; Casein Kinase II; Computer Simulation; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Indazoles; Injections, Intraperitoneal; Nephritis; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrazines; Rats; Structure-Activity Relationship

2012
[Ligustrazine and cimetidine therapy for the prevention of Henoch-Schonlein purpura nephritis in children: a follow-up study of 380 cases].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2007, Volume: 9, Issue:5

    Topics: Child; Cimetidine; Female; Follow-Up Studies; Humans; IgA Vasculitis; Male; Nephritis; Pyrazines

2007
Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.
    Nephron, 1997, Volume: 76, Issue:3

    Topics: Animals; Antioxidants; Dipyridamole; Free Radical Scavengers; Immune Complex Diseases; Kidney; Kidney Cortex; Lipid Peroxidation; Male; Malondialdehyde; Nephritis; Phosphatidylcholines; Prednisolone; Proteinuria; Pyrazines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides

1997